CDT Equity Q1 FY26 net loss narrows 14.52% to $4.06 million

Conduit Pharmaceuticals

Conduit Pharmaceuticals

CDT

0.00
  • CDT Equity posted a net loss of USD 4.06 million for Q1 2026, narrowing from USD 4.75 million a year earlier.
  • Operating loss widened to USD 3.66 million, as operating costs edged up to USD 3.66 million from USD 3.62 million.
  • R&D expense fell 15% to USD 778,000, while general and administrative costs rose 7% to USD 2.88 million.
  • Other expense narrowed to USD 407,000 from USD 1.14 million, while loss on equity method investment was USD 68,000 after a Sarborg stake.
  • Cash used in operations improved to USD 1.89 million from USD 3.93 million, while management flagged substantial doubt about going-concern status.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033380), on July 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.